BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baumann R, Chan MKH, Pyschny F, Stera S, Malzkuhn B, Wurster S, Huttenlocher S, Szücs M, Imhoff D, Keller C, Balermpas P, Rades D, Rödel C, Dunst J, Hildebrandt G, Blanck O. Clinical Results of Mean GTV Dose Optimized Robotic-Guided Stereotactic Body Radiation Therapy for Lung Tumors. Front Oncol 2018;8:171. [PMID: 29868486 DOI: 10.3389/fonc.2018.00171] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Watanabe S, Yamazaki H, Kimoto T, Shiomi H, Yamada K, Suzuki G. Potential benefit of dose‐escalated stereotactic body radiation therapy using CyberKnife for early‐stage primary lung cancer. Asia-Pac J Clncl Oncology. [DOI: 10.1111/ajco.13842] [Reference Citation Analysis]
2 Nierer L, Eze C, da Silva Mendes V, Braun J, Thum P, von Bestenbostel R, Kurz C, Landry G, Reiner M, Niyazi M, Belka C, Corradini S. Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate. Radiat Oncol 2022;17. [DOI: 10.1186/s13014-022-02021-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zeverino M, Jia Y, Charosky L, Bourhis J, Bochud FO, Moeckli R. On the interplay effect for moving targets treated with the CyberKnife static tracking system. Phys Med 2021;90:30-9. [PMID: 34530213 DOI: 10.1016/j.ejmp.2021.08.016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Avanzo M, Gagliardi V, Stancanello J, Blanck O, Pirrone G, El Naqa I, Revelant A, Sartor G. Combining computed tomography and biologically effective dose in radiomics and deep learning improves prediction of tumor response to robotic lung stereotactic body radiation therapy. Med Phys 2021;48:6257-69. [PMID: 34415574 DOI: 10.1002/mp.15178] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
5 Bousabarah K, Blanck O, Temming S, Wilhelm ML, Hoevels M, Baus WW, Ruess D, Visser-Vandewalle V, Ruge MI, Treuer H, Kocher M. Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two independent institutions. Radiat Oncol 2021;16:74. [PMID: 33863358 DOI: 10.1186/s13014-021-01805-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Stera S, Miebach G, Buergy D, Dreher C, Lohr F, Wurster S, Rödel C, Marcella S, Krug D, Frank A G, Ehmann M, Fleckenstein J, Blanck O, Boda-Heggemann J. Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases: An outcome analysis of a pooled multi-platform patient cohort. Radiother Oncol 2021;158:230-6. [PMID: 33667585 DOI: 10.1016/j.radonc.2021.02.036] [Reference Citation Analysis]
7 Lydiard, Pgdip S, Blanck O, Hugo G, O’brien R, Keall P. A Review of Cardiac Radioablation (CR) for Arrhythmias: Procedures, Technology, and Future Opportunities. International Journal of Radiation Oncology*Biology*Physics 2021;109:783-800. [DOI: 10.1016/j.ijrobp.2020.10.036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
8 Wilhelm ML, Chan MKH, Abel B, Cremers F, Siebert FA, Wurster S, Krug D, Wolff R, Dunst J, Hildebrandt G, Schweikard A, Rades D, Ernst F, Blanck O. Tumor-dose-rate variations during robotic radiosurgery of oligo and multiple brain metastases. Strahlenther Onkol 2021;197:581-91. [PMID: 32588102 DOI: 10.1007/s00066-020-01652-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Heng VJ, Renaud MA, Zerouali K, Doucet R, Diamant A, Bahig H, DeBlois F, Seuntjens J. Large-scale dosimetric assessment of Monte Carlo recalculated doses for lung robotic stereotactic body radiation therapy. Phys Med 2020;76:7-15. [PMID: 32569954 DOI: 10.1016/j.ejmp.2020.06.006] [Reference Citation Analysis]
10 Merlotti A, Bonomo P, Ragona R, Trovò M, Alongi F, Mazzola R, Vigna Taglianti R, Gianello L, Reali A, Bergesio F, Lucio F, Boriano A, De Maggi A, Russi E. Dose prescription in SBRT for early-stage non-small cell lung cancer: are we all speaking the same language? Tumori 2021;107:182-7. [PMID: 32515301 DOI: 10.1177/0300891620929425] [Reference Citation Analysis]
11 Leung RWK, Chan MKH, Chiang CL, Wong M, Blanck O. On the pitfalls of PTV in lung SBRT using type-B dose engine: an analysis of PTV and worst case scenario concepts for treatment plan optimization. Radiat Oncol 2020;15:130. [PMID: 32471457 DOI: 10.1186/s13014-020-01573-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Grassberger C, Huber K, Jacob NK, Green MD, Mahler P, Prisciandaro J, Dominello M, Joiner MC, Burmeister J. Three discipline collaborative radiation therapy (3DCRT) special debate: The single most important factor in determining the future of SBRT is immune response. J Appl Clin Med Phys 2019;20:6-12. [PMID: 31573143 DOI: 10.1002/acm2.12728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Hass P, Mohnike K, Kropf S, Brunner TB, Walke M, Albers D, Petersen C, Damm R, Walter F, Ricke J, Powerski M, Corradini S. Comparative analysis between interstitial brachytherapy and stereotactic body irradiation for local ablation in liver malignancies. Brachytherapy 2019;18:823-8. [PMID: 31522972 DOI: 10.1016/j.brachy.2019.08.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
14 Bousabarah K, Temming S, Hoevels M, Borggrefe J, Baus WW, Ruess D, Visser-Vandewalle V, Ruge M, Kocher M, Treuer H. Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy. Strahlenther Onkol 2019;195:830-42. [PMID: 30874846 DOI: 10.1007/s00066-019-01452-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
15 Wilke L, Andratschke N, Blanck O, Brunner TB, Combs SE, Grosu AL, Moustakis C, Schmitt D, Baus WW, Guckenberger M. ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams : Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlenther Onkol 2019;195:193-8. [PMID: 30649567 DOI: 10.1007/s00066-018-1416-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 72] [Article Influence: 15.0] [Reference Citation Analysis]
16 Barillot I, Antoni D, Bellec J, Biau J, Giraud P, Jenny C, Lacornerie T, Lisbona A, Marchesi V, Mornex F, Supiot S, Thureau S, Noel G. Bases référentielles de la radiothérapie en conditions stéréotaxiques pour les tumeurs ou métastases bronchopulmonaires, hépatiques, prostatiques, des voies aérodigestives supérieures, cérébrales et osseuses. Cancer/Radiothérapie 2018;22:660-81. [DOI: 10.1016/j.canrad.2018.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]